Stock Information
AnaptysBio Inc (ANAB)
Ticker Symbol: ANAB
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,945.68 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.3173
Revenue (TTM): $8.45 M
Dividend Yield: N/A%
ROE: 28.88%
Latest News
-
HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $66 Price Target
Mon, Mar 30, 2026 8:45 AM
-
AnaptysBio Announces $100M Buyback Plan; Announces To Manage Financial Partnership For Jemperli With GSK And Imsidolimab With Vanda After Planned Spin-Off Of First Tracks Biotherapeutics
Fri, Mar 27, 2026 9:05 AM
-
Anaptys Announces $100M Share Buyback Program
Fri, Mar 27, 2026 9:04 AM
Key Financials
Financial data not available
